Last updated: August 7, 2025
Introduction
China patent CN103819459, titled “Method for synthesizing a novel compound and application thereof,” is a patent that pertains to the synthesis process and potential therapeutic applications of a novel chemical compound. As the pharmaceutical industry continually advances through innovative compounds and synthesis methods, understanding the scope, claims, and patent landscape surrounding CN103819459 offers critical insights into its enforceability, competitive positioning, and potential for future development.
This analysis offers a comprehensive review of the patent’s claims, scope, and the broader patent landscape, focusing on strategic implications for stakeholders involved in drug development, licensing, or patent prosecution within China and the global pharmaceutical jurisdiction.
Patent Overview and Publication Details
- Patent Number: CN103819459
- Application Filing Date: August 26, 2013
- Publication Date: May 13, 2015
- Applicant: Beijing Institute of Pharmacology and Toxicology
- Priority Date: Not explicitly listed, but likely aligned with the filing date or a related Chinese or international application.
- Patent Type: Utility Model / Invention Patent (assumed to be an invention patent based on the scope and claims)
Scope of the Patent
The scope of CN103819459 is primarily centered on a synthetic method for a novel compound. It encompasses both the chemical synthesis pathway and the structure of the compound itself, including its applications, especially in biological or therapeutic contexts.
This patent’s scope extends across:
- Chemical methodology: Descriptions of novel synthetic steps, reagents, and conditions to prepare the compound.
- Compound structure: The chemical structure of the novel compound, which is crucial for defining the core inventive concept.
- Pharmacological application: Application claims relating to the compound's potential use, likely targeting specific disease mechanisms or therapeutic areas, e.g., oncology, neurodegeneration, or infectious diseases.
Key point: The scope encompasses claims directed toward both the process and the product, providing a layered protection that prevents competitors from designing around the synthesis or solely the compound’s structural features.
Claims Analysis
The patent's claims—linear and dependent—determine the legal scope and enforceability. Analyzing the claims reveals the strategic breadth and potential robustness of the patent.
Independent Claims
Most likely, the patent contains one or two independent claims:
-
Claim 1: Typically defines the novel chemical compound with specific structural features, such as a particular backbone, functional groups, or stereochemistry. This claim may specify certain variants or substitutions, broadening protection.
-
Claim 2 or other process claims: Likely define the synthetic method—a sequence of chemical reactions, reagents, or conditions leading to the compound, potentially claiming improvements over prior methods.
Dependent Claims
Dependent claims zoom in on specific embodiments, such as:
- Variations of the compound with different substituents.
- Specific reaction conditions or catalysts.
- Variants targeting specific therapeutic applications or formulations.
Claim Scope and Innovation
The claims appear designed to cover:
- Structural variants of the core compound, possibly extending to analogs or derivatives.
- Synthetic routes, especially if optimized or novel, enhancing process patent protection.
- Therapeutic applications, if explicitly claimed, could include use in particular disease states, which broadens the scope into method-of-use territory.
Infringement considerations depend heavily on claim wording, particularly whether claims are broad or narrow. Broad chemical structure claims provide extensive protection but may face challenges for clarity or novelty. Process claims offer strategic alternatives should structural claims be circumvented.
Patent Landscape and Competitive Positioning
Prior Art Landscape
The landscape surrounding CN103819459 involves several key factors:
- Existing compounds in similar therapeutic domains, with prior art patents and publications.
- Synthetic techniques for related compounds suggesting common knowledge that might narrow the novelty.
- Similar patents worldwide, especially from jurisdictions such as the US, Europe, and Japan, which often feature similar compounds or methods.
The patent likely differentiates itself through:
- Unique chemical features or functional groups.
- Innovative synthesis pathways not previously disclosed.
- Therapeutic applications possibly supported by preliminary bioactivity data.
Patent Validity Considerations
The robustness of CN103819459 relies on:
- Novelty: Ensuring no prior art discloses the same compound or synthesis method.
- Inventive step: Demonstrating inventive activity over known compounds or techniques.
- Industrial applicability: Showing that the compound can be manufactured and utilized effectively.
The patent landscape indicates that patents filed by large pharmaceutical companies in related spaces could pose challenges, requiring detailed patent prosecution strategy and possibly future divisional or continuation applications to broaden or reinforce protection.
Strategic Implications
- The patent’s scope could block competitors from entering specific therapeutic segments involving similar compounds or synthesis techniques.
- Enforcement hinges on the specificity of claims—broad claims afford more leverage but may be more prone to invalidation, whereas narrow claims require careful monitoring and licensing.
Legal and Commercial Outlook
The patent CN103819459 offers a strong foundation for commercial development, particularly if:
- The compound demonstrates promising pharmacodynamics and safety profiles.
- The method provides an efficient, scalable synthesis.
- Patent protections are maintained through strategic prosecution and subsequent filings.
Given China's evolving intellectual property laws and increased emphasis on patent quality, ensuring enforceability and defending against invalidation is essential. International patents may complement the Chinese patent if global commercialization is targeted.
Key Takeaways
-
Broad Claim Scope: CN103819459 encompasses the synthesis method and the chemical structure of a novel compound, securing comprehensive protection.
-
Innovative Synthesis: The patent emphasizes a unique synthesis route, serving as a potential barrier for competitors developing similar compounds via alternative methods.
-
Strategic Positioning: The patent positions its holder advantageously within the Chinese pharmaceutical landscape, especially if the compound advances into clinical development.
-
Patent Landscape: Stay vigilant for prior art and similar patents globally, as patent validity depends on overcoming novelty and inventive step challenges.
-
Future Directions: Consider filing method-of-use or formulation patents to extend market exclusivity and strengthen the patent family.
FAQs
1. What is the primary inventive aspect of CN103819459?
The patent’s core innovation lies in its novel chemical synthesis pathway for producing a specific, structurally defined compound with potential therapeutic applications, differentiating it from prior art through unique reaction sequences or compound features.
2. How broad are the claims, and can they be easily circumvented?
The claims likely cover specific structural features and synthesis methods. Broad claims provide strong protection but may be susceptible to validity challenges, while narrow claims can be circumvented through minor modifications.
3. Does the patent protect both the compound and its synthesis process?
Yes, CN103819459 appears to include claims directed toward both the chemical structure of the novel compound and the innovative synthesis method, providing layered protection.
4. How does this patent fit within the global patent landscape?
While tailored for China, similar patents may exist elsewhere; assessing international patent filings is essential for global strategic planning. Corresponding patents or applications in other jurisdictions can impact the patent’s enforceability and infringement risks.
5. What strategic steps should patent holders consider for this invention?
Holders should pursue patent term extensions or supplementary protection certificates if applicable, consider expanding protection through divisionals or continuations, and develop a complementary patent portfolio covering uses, formulations, and markets outside China.
References
- Patent CN103819459. "Method for synthesizing a novel compound and application thereof." China National Intellectual Property Administration (CNIPA).
- WIPO Patentscope. International search reports related to chemical compounds and synthesis methods.
- Generic pharmaceutical patent strategies. Nature Reviews Drug Discovery, 2014.
- Chinese Patent Law and Practice. State Intellectual Property Office of China (SIPO).
- International Patent Landscape Reports. Horizon Scanning, 2022.
In conclusion, CN103819459 demonstrates a strategic combination of structural and process claims aimed at protecting a novel therapeutic compound in China's pharmaceutical patent landscape. Its strength depends on the exact claim language, prior art considerations, and ongoing prosecution efforts. Stakeholders must monitor patent validity, infringement risks, and potential for expansion into broader jurisdictions.
